2-Deoxy-d-glucose as a potential drug against fusogenic viruses including HIV

Medical Hypotheses

Volumn 70, Issue 4, 2008, Pages 776-782

  Parris, George E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORO 2 DEOXY DEXTRO MANNOSE; ASPARAGINE; CHLOROQUINE; DEOXYGLUCOSE; ENFUVIRTIDE; FLUORODEOXYGLUCOSE; GLYCOSIDASE; MANNOSE; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN GP41; TUNICAMYCIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CATALYSIS; CELL FUSION; CLINICAL TRIAL; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG MECHANISM; GLYCOLYSIS; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEOPLASM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; SIDE EFFECT; SUGAR TRANSPORT; TERATOGENESIS; VIRUS INFECTION; VIRUS INFECTIVITY;

CANIS FAMILIARIS;

EID: 39849109365     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.08.021     Document Type: Article

References (76)

1. G. Parris The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis (II): three pathways for spontaneous cell–cell fusion and escape from the intercellular matrix Med Hypotheses 67 2006 172 176
2. G.E. Parris The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis (I): history and experimental support Med Hypotheses 66 2006 76 83
3. G.E. Parris Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species Med Hypotheses 65 2005 846 850
4. G.E. Parris The role of viruses in cell fusion and its importance to evolution, invasion and metastasis of cancer clones Med Hypotheses 64 2005 1011 1014
5. A.K. Chakaraborty J.M. Pawelek GnT-V, macrophage and cancer metastasis: a common link Clin Exp Metastasis 20 2003 365 373
6. A.K. Charakraborty F. Sousa Jde D. Chakraborty GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription Gene 374 2006 166 173
7. A.K. Chakraborty J. Pawelek Y. Ikeda Fusion hybrids with macrophage and melanoma cells up-regulate N -acetylglucosaminyltransferase V, beta1-6 branching, and metastasis Cell Growth Differ 12 2001 623 630
8. D.M. Duelli H.M. Padilla-Nash D. Berman K.M. Murphy T. Ried Y. Lazebnik A virus causes cancer by inducing massive chromosomal instability through cell fusion Curr Biol 17 2007 431 437
9. D.M. Duelli S. Hearn M.P. Myers Y. Lazebnik A primate virus generates transformed human cells by fusion J Cell Biol 171 2005 493 503
10. Parris GE. Mechanism and history of evolution of symbiotic HIV strains into lethal pandemic strains: the key event may have been a 1927 trial of pamaquine in Leopoldville (Kinshasa), Congo. Med Hypotheses, in press [Epub March 15, 2007].
11. A. Savarino M.B. Lucia E. Rastrelli Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors J Acquir Immune Defic Syndr 35 2004 223 232
12. M.J. Vincent E. Bergeron S. Benjannet Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Virol J 2 2005 69
13. E.M. Burns L. Christopoulou P. Corish C. Tyler-Smith Quantitative measurement of mammalian chromosome mitotic loss rates using the green fluorescent protein J Cell Sci 112 1999 2705 2714
14. P. Duesberg R. Li A. Fabarius R. Hehlmann Aneuploidy and cancer: from correlation to causation Contrib Microbiol 13 2006 16 44
15. P.D. Keightley S.P. Otto Interference among deleterious mutations favours sex and recombination in finite populations Nature 443 2006 89 92
16. K. Ypshida S. Obata M. Ono M. Esaki T. Maejima H. Sawada TPA-induced multinucleation of a mesenchymal stem cell-like clone is mediated primarily by karyokinesis without cytokinesis, although cell–cell fusion also occurs Eur J Cell Biol Jun 26 2007 [Epub ahead of print]
17. J.C. Lin M.C. Smith J.S. Pagano Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter J Virol 45 1983 985 991
18. L. Eliasson M.T. Nilsson B. Kallin G. Klein Epstein-Barr virus and tumor promoters Princess Takamatsu Symp 14 1983 139 145
19. G.J. Bayliss H. Wolf An Epstein-Barr virus early protein induces cell fusion Proc Natl Acad Sci USA 78 1981 7162 7165
20. T.J. Lampidis M. Kurtoglu J.C. Maher Efficacy of 2-halogen substituted d -glucose analogs in blocking glycolysis and killing “hypoxic tumor cells” Cancer Chemother Pharmacol 58 2006 725 734
21. M. Kurtoglu J.C. Maher T.J. Lampidis Differential toxic mechanisms of 2-deoxy- d -glucose versus 2-fluorodeoxy- d -glucose in hypoxic and normoxic tumor cells Antioxid Redox Signal July 13 2007 [Epub ahead of print]
22. M. Hatanaka J.C. Graff Hexose transport in sarcoma virus transformed cells Bibl Haematol 1975 621 625
23. D. Brust M. Polis R. Davey Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation AIDS 20 2006 985 993
24. Bicher HI, Anti-cancer compositions containing chiral monosaccharides and methods of their use, US patent 5449663 issued in 1995 and assigned to Valley Cancer Institute in Los Angeles, CA, also see US5624908 issued in 1997.
25. D.K. Ingram R.M. Anson R. de Cabo Development of calorie restriction mimetics as a prolongevity strategy Ann NY Acad Sci 1019 2004 412 423
26. G.S. Roth M.A. Lane D.K. Ingram Caloric restriction mimetics: the next phase Ann NY Acad Sci 1057 2005 365 371
27. R. Vijayaraghavan D. Kumar S.N. Dube Acute toxicity and cardio-respiratory effects of 2-deoxy- d -glucose: a promising radio sensitiser Biomed Environ Sci 19 2006 96 103
28. I.F. Tannock P. Guttman A.M. Rauth Failure of 2-deoxy- d -glucose and 5-thio- d -glucose to kill hypoxic cells of two murine tumors Cancer Res 43 1983 980 983
29. O. Kaplan G. Navon R.C. Lyon P.J. Faustino E.J. Straka J.S. Cohen Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism Cancer Res 50 1990 544 551
30. E. Olivares W.J. Malaisse Potentiation by 2-deoxy- d -glucose tetraacetate of the cytostatic action of alpha-difluoromethylornithine in tumoral insulin-producing cells Oncol Rep 5 1998 1395 1397
31. U. Reinhold W.J. Malaisse Cytotoxic action of 2-deoxy- d -glucose tetraacetate upon human lymphocytes, fibroblasts and melanoma cells Int J Mol Med 1 1998 427 430
32. R.A. Gatenby R.J. Gillies Glycolysis in cancer: a potential target for therapy Int J Biochem Cell Biol April 4 2007 [Epub ahead of print]
33. R.L. Aft F.W. Zhang D. Gius Evaluation of 2-deoxy- d -glucose as a chemotherapeutic agent: mechanism of cell death Br J Cancer 87 2002 805 812
34. K.A. Kern J.A. Norton Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy- d -glucose Surgery 102 1987 380 385
35. X. Lin F. Zhang C.M. Bradbury 2-Deoxy- d -glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism Cancer Res 63 2003 3413 3417
36. G. Maschek N. Savaraj W. Priebe 2-deoxy- d -glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo Cancer Res 64 2004 31 34
37. J.C. Maher A. Krishan T.J. Lampidis Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy- d -glucose in tumor cells treated under hypoxic vs aerobic conditions Cancer Chemother Pharmacol 53 2004 116 122
38. B.S. Dwarakanath D. Khaitan T. Ravindranath 2-Deoxy- d -glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines Cancer Biol Ther 3 2004 864 870
39. S. Gupta R. Mathur B.S. Dwarakanath The glycolytic inhibitor 2-deoxy- d -glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice Cancer Biol Ther 4 2005 87 94
40. K. Zhang R.J. Kaufman Protein folding in the endoplasmic reticulum and the unfolded protein response Handbook Exp Pharmacol 172 2006 69 91
41. M. Molinari N -glycan structure dictates extension of protein folding or onset of disposal Nat Chem Biol 3 2007 313 320
42. Kobata A, Amano J. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 2005; 83:429-439.
43. G. Bolt C. Kristensen T.D. Steenstrup Posttranslational N -glycosylation takes place during the normal processing of human coagulation factor VII Glycobiology 15 2005 541 547
44. J. Zhao W. Oiu D.M. Simone D.M. Lubman N -linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis J Proteome Res 6 2007 1126 1138
45. S. Banerji A.J. Wright M. Noble Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction Nat Struct Mol Biol 14 2007 234 239
46. F. Zheng L. Ma L. Shao Envelope glycoproteins of hantavirus can mediate cell–cell fusion independently New Microbiol 30 2007 101 107
47. J.S. Jones R. Risser Cell fusion induced by the murine leukemia virus envelope glycoprotein J Virol 67 1993 67 74
48. N. Lopez-Balderas L. Huerta C. Villarreal In vitro cell fusion between CD4(+) and HIV-1 Env(+) T cells generates a diversity of syncytia varying in total number, size and cellular content Virus Res 123 2007 138 146
49. N. Loch C.C. Geilen I. Spurndle 2-Deoxy-2-fluoro- d -galactose protein N -glycosylation FEBS Lett 294 1991 217 220
50. V. Gross W.E. Hull U. Berger Inhibition of protein N -glycosylation by 2-deoxy-2-fluoro- d -galactose Biochem J 285 1992 821 826
51. H. Ludwig H. Becht R. Rott Inhibition of herpes virus-induced cell fusion by concanavalin A, antisera, and 2-deoxy- d -glucose J Virol 14 1974 307 314
52. H. Ludwig R. Rott Effect of 2-deoxy- d -glucose on herpesvirus-induced inhibition of cellular DNA synthesis J Virol 16 1975 217 221
53. M.F. Schmidt R.T. Schwarz H. Ludwig Fluorosugars inhibit biological properties of different enveloped viruses J Virol 18 1976 819 823
54. H. Sato T. Takimoto S. Tanaka H. Ogura K. Shiraishi J. Tanaka Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells J Virol 63 1989 3555 3559
55. T. Yoshizaki T. Takimoto H. Takeshita Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line Laryngoscope 104 1994 91 94
56. E.L. Delwart A.T. Panganiban N -linked glycosylation and reticuloendotheliosis retrovirus envelope glycoprotein function Virology 179 1990 648 657
57. M.A. Naarding E. Baan G. Pollakis W.A. Paxton Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes Retrovirology 4 2007 6
58. B. Dash A. McIntosh W. Barrett R. Daniels Deletion of a single N -linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion J Gen Virol 75 1994 1389 1397
59. E. Fenouillet I.M. Jones The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160 J Gen Virol 76 1995 1509 1514
60. R.L. Willey R. Shibata E.O. Freed M.W. Cho M.A. Martin Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures J Virol 70 1996 6431 6436
61. Y. Li M.A. Rey-Cuille S.L. Hu N -linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection AIDS Res Hum Retroviruses 17 2001 1473 1479
62. J. Wang G.J. Babcock H. Choe M. Farzan J. Sodroski D. Gabuzda N -linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins Virology 324 2004 140 150
63. S. Miyagaw S. Nakatsu K. Hazama A novel strategy for preventing PERV transmission to human cells by remodeling the viral envelope glycoprotein Xenotransplantation 13 2006 258 263
64. L.R. Sorbara F. Maldarelli G. Chamoun Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression J Virol. 70 1996 7275 7279
65. A.M. Scharko S.B. Perlman R.W. Pyzalski F.M. Graziano J. Sosman C.D. Pauza Whole-body positron emission tomography in patients with HIV-1 infection Lancet 362 2003 959 961
66. F. De Winter D. Vogelaers F. Gemmel R.A. Dierckx Promising role of 18-F-fluoro- d -deoxyglucose positron emission tomography in clinical infectious diseases Eur J Clin Microbiol Infect Dis 21 2002 247 257
67. H.A. Blough R. Pauwels E. De Clercq J. Cogniaux S. Sprecher-Goldberger L. Thiry Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins Biochem Biophys Res Commun 141 1986 33 38
68. D.C. Montefiori W.E. Robinson W.M. Mitchell Role of protein N -glycosylation in pathogenesis of human immunodeficiency virus type 1 Proc Natl Acad Sci USA 85 1988 9248 9252
69. Blough HA, 2-Deoxy glucose as an antiviral agent against herpes simplex. United States Patent 4315001, issued in 1986 (expired).
70. D. Kilbourne Inhibition of influenza virus multiplication with a glucose antimetabolite (2-deoxy- d -glucose) Nature 183 1959 271 272
71. S. Pohlmann J.D. Reeves Cellular entry of HIV: evaluation of therapeutic targets Curr Pharm Des 12 2006 1963 1973
72. A. Lazzarin Enfuvirtide: the first HIV fusion inhibitor Expert Opin Pharmacother 6 2005 453 464
73. J. Hornberger J.M. Kilby Green J. Wintfeld Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States AIDS Res Hum Retroviruses 22 2006 240 247
74. J.S. James T-20: most expensive AIDS drug ever at $25,000 per year? AIDS Treat News March 14 2003 6 7
75. F. Urner D. Sakkas Glucose participates in sperm–oocyte fusion in the mouse Biol Reprod 55 1996 917 922
76. E.S. Hunter J.A. Tugman Inhibitors of glycolytic metabolism affect neurulation-staged mouse conceptuses in vitro Teratology 52 1995 317 323